1. Home
  2. GKOS vs GLOB Comparison

GKOS vs GLOB Comparison

Compare GKOS & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • GLOB
  • Stock Information
  • Founded
  • GKOS 1998
  • GLOB 2003
  • Country
  • GKOS United States
  • GLOB Luxembourg
  • Employees
  • GKOS N/A
  • GLOB N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • GLOB EDP Services
  • Sector
  • GKOS Health Care
  • GLOB Technology
  • Exchange
  • GKOS Nasdaq
  • GLOB Nasdaq
  • Market Cap
  • GKOS 5.8B
  • GLOB 4.7B
  • IPO Year
  • GKOS 2015
  • GLOB 2014
  • Fundamental
  • Price
  • GKOS $103.50
  • GLOB $92.49
  • Analyst Decision
  • GKOS Strong Buy
  • GLOB Buy
  • Analyst Count
  • GKOS 13
  • GLOB 16
  • Target Price
  • GKOS $135.15
  • GLOB $174.94
  • AVG Volume (30 Days)
  • GKOS 903.0K
  • GLOB 1.0M
  • Earning Date
  • GKOS 07-30-2025
  • GLOB 08-14-2025
  • Dividend Yield
  • GKOS N/A
  • GLOB N/A
  • EPS Growth
  • GKOS N/A
  • GLOB N/A
  • EPS
  • GKOS N/A
  • GLOB 3.38
  • Revenue
  • GKOS $404,523,000.00
  • GLOB $2,455,696,000.00
  • Revenue This Year
  • GKOS $27.88
  • GLOB $4.36
  • Revenue Next Year
  • GKOS $27.60
  • GLOB $6.03
  • P/E Ratio
  • GKOS N/A
  • GLOB $27.14
  • Revenue Growth
  • GKOS 23.92
  • GLOB 11.90
  • 52 Week Low
  • GKOS $77.10
  • GLOB $86.02
  • 52 Week High
  • GKOS $163.71
  • GLOB $238.32
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 61.38
  • GLOB 41.60
  • Support Level
  • GKOS $100.92
  • GLOB $90.40
  • Resistance Level
  • GKOS $106.52
  • GLOB $94.59
  • Average True Range (ATR)
  • GKOS 3.30
  • GLOB 2.97
  • MACD
  • GKOS 0.37
  • GLOB 0.79
  • Stochastic Oscillator
  • GKOS 71.27
  • GLOB 49.01

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About GLOB Globant S.A.

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

Share on Social Networks: